Piperacillin-Tazobactam
Antipseudomonal Penicillin + β-Lactamase Inhibitor- Drug Class
- Antipseudomonal Penicillin + β-Lactamase Inhibitor
- Mechanism of Action (MOA)
- Piperacillin inhibits PBPs; tazobactam shields it from β-lactamases → broad coverage.
- Clinical Notes
- Broad empiric coverage incl. Pseudomonas and anaerobes; common for HAP and intra-abdominal infection. No MRSA or atypical coverage.
- Source
- FDA label (DailyMed)
Sources
Reviewed June 2026- FDA label (DailyMed) — FDA / DailyMed
Checked against the guideline or standard reference the exam keys to. If it has moved, use Report an error below.
Same family
Got a pharmacology lecture that covers Piperacillin-Tazobactam? Turn it into flashcards and board-style questions, free. Drop it on the home page
All pharmacology